Menu
Oslo, 11 April 2025
Ludvik Sandnes, Chairman of the Board at Thor Medical ASA (the "Company"), has received proxies without voting instructions to vote for a total of 15,786,906 shares at the Company's Annual General Meeting on 24 April 2025, representing approx. 5.00 percent of all shares in the Company. Additionally, Sandnes has received proxies with voting instructions to vote for a total of 3,046,978 shares at the Company's Annual General Meeting on 24 April 2025, representing approx. 0.97 percent of all shares in the Company.
Furthermore, Sandnes owns 626,489 shares, representing approx. 0.20 percent of all shares issued in the Company, as well as 300,000 shares, representing approx. 0.10 percent of all issued shares in the Company through Ekornhuset AS. Sandnes will be able to cast votes at the Annual General Meeting for a total of 19,760,375 shares, representing approx. 6.27 percent of all issued shares in the Company.
The received proxies are valid only for the aforementioned General Meeting and will automatically expire, so that after the General Meeting, Sandnes will own 926,489 shares in the Company, including the shares owned by Ekornhuset AS.
This notification is issued because Sandnes has been granted proxies without voting instructions for more than 5% of all voting rights in the Company. The notification does not indicate that the aforementioned is the final number of shares Sandnes will be able to vote for at the Annual General Meeting.
This information is subject to disclosure requirements pursuant to Section 4-2 of the Securities Trading Act.
